
The healthcare company reported higher third-quarter adjusted earnings and raised its profit and cash flow targets for the full year.
CVS Health raised its full-year 2026 earnings and cash flow guidance after third-quarter revenue increased 5.4% to $108.4 billion. Adjusted earnings per share were $2.09, up from $1.60 a year earlier.
The company now expects adjusted EPS of at least $8.20, compared with its previous range of $7.90 to $8.10. It raised its operating cash flow outlook to at least $15.5 billion from at least $11.5 billion, and its GAAP diluted EPS outlook to at least $6.98 from a range of $6.84 to $7.04.
CVS said the revised outlook reflects higher results in its Health Care Benefits and Pharmacy & Consumer Wellness segments. It also said it remains cautious about the rest of the year because health care cost trends remain elevated and macroeconomic headwinds are possible.
Third-quarter GAAP diluted EPS was $1.68, versus a loss of $3.13 a year earlier. CVS attributed the improvement primarily to the absence of a $5.7 billion goodwill impairment charge recorded in the prior-year quarter. Adjusted operating income in Health Care Benefits rose to $912 million from $314 million.
As of Wednesday afternoon, CVS shares traded at $80.69, down 11.73% since the previous close.
This article was produced with the help of AI technology. Based on reporting by the outlets listed above.